Targeted delivery of a colchicine analogue provides synergy with ATR inhibition in cancer cells
KeywordMT1-MMP (Membrane type 1 matrix metalloproteinase)
ATR (Ataxia telangiectasia and Rad3 related kinase)
VDA (Vascular disrupting agent)
Rights© 2022 The Authors. Published by Elsevier Inc. This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Open Access statusopenAccess